The latest closing stock price for Qualigen Therapeutics as of November 25, 2024 is 4.78.
An investor who bought $1,000 worth of Qualigen Therapeutics stock at the IPO in 2015 would have $-1,000 today, roughly -1 times their original investment - a -72.97% compound annual growth rate over 9 years.
The all-time high Qualigen Therapeutics stock closing price was 620000.00 on June 24, 2015.
The Qualigen Therapeutics 52-week high stock price is 39.13, which is 718.6% above the current share price.
The Qualigen Therapeutics 52-week low stock price is 3.34, which is 30.1% below the current share price.
The average Qualigen Therapeutics stock price for the last 52 weeks is 15.74.
An investor who bought $1,000 worth of Qualigen Therapeutics stock at the IPO in 2015 would have $-1,000 today, roughly -1 times their original investment - a -72.97% compound annual growth rate over 9 years.
The all-time high Qualigen Therapeutics stock closing price was 620000.00 on June 24, 2015.
The Qualigen Therapeutics 52-week high stock price is 39.13, which is 718.6% above the current share price.
The Qualigen Therapeutics 52-week low stock price is 3.34, which is 30.1% below the current share price.
The average Qualigen Therapeutics stock price for the last 52 weeks is 15.74.